Visible‐Light‐Induced Controlled Oxidation of
<i>N</i>
‐Substituted 1,2,3,4‐Tetrahydroisoquinolines for the Synthesis of 3,4‐Dihydroisoquinolin‐1(2
<i>H</i>
)‐ones and Isoquinolin‐1(2
<i>H</i>
)‐ones
作者:Ajay H. Bansode、Gurunath Suryavanshi
DOI:10.1002/adsc.202001266
日期:2021.3.2
controlled oxidation of N‐substituted 1,2,3,4‐tetrahydroisoquinolines is developed for the synthesis of 3,4‐dihydroisoquinolin‐1(2H)‐ones and isoquinolin‐1(2H)‐ones. The present method feature's a broad substrate scope, good functional group tolerances, and the products were prepared in good to excellent yields. The developed methodology further demonstrated in the synthesis of isoindolo[2,1‐b] isoquinolin‐5(7H)‐one
An efficient method for the synthesis of substituted 1(2H)-isoquinolone derivatives via nickel-catalyzed annulation of substituted 2-halobenzamides with alkynes is described. This protocol is successfully applied to the total synthesis of oxyavicine with excellent yield.
I
<sub>2</sub>
‐Promoted Direct C−H Sulfenylation of Isoquinolin‐1(2
<i>H</i>
)‐ones with Sulfonyl Chlorides
作者:Cai‐Yun Yang、Xia Li、Bo Liu、Guo‐Li Huang
DOI:10.1002/ejoc.202001371
日期:2021.1.8
conditions was described. These methods provide an alternative and facile synthetic route to access a series of 4‐arylthio‐substituted isoquinolin‐1(2H)‐one derivatives in moderate to good yields. This is a useful, time‐efficient, and scalable procedure for the construction of C(sp2)−S bonds.
[EN] ISOQUINOLINONE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS<br/>[FR] DERIVES D'ISOQUINOLINONE ET LEUR UTILISATION COMME AGENTS THERAPEUTIQUES
申请人:X CEPTOR THERAPEUTICS INC
公开号:WO2004058717A1
公开(公告)日:2004-07-15
This invention is directed to isoquinolinone derivatives and their use in modulating the activity of orphan nuclear receptors, pharmaceutical compositions containing such derivatives, and methods of using such derivatives in treating disease-states associated with nuclear receptor activity.